First Light Asset Management LLC Has $3.06 Million Stake in Senseonics Holdings, Inc. $SENS

Key Points

• First Light Asset Management LLC has reduced its stake in Senseonics Holdings, Inc. by 27.6%, now owning approximately 4.66 million shares valued at $3.06 million.
• Senseonics has received several analyst ratings with a consensus rating of "Buy" and an average target price of $1.54, with Barclays giving an "overweight" rating and a $1.50 price target.
• As of now, Senseonics shares are trading at $0.46, with a market cap of approximately $374.35 million and a price-to-earnings ratio of -3.53.

First Light Asset Management LLC reduced its stake in Senseonics Holdings, Inc. (NYSE:SENS - Free Report) by 27.6% in the 1st quarter, according to the company in its most recent filing with the SEC. The fund owned 4,657,505 shares of the company's stock after selling 1,774,294 shares during the quarter. First Light Asset Management LLC owned approximately 0.71% of Senseonics worth $3,056,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. IFP Advisors Inc lifted its holdings in Senseonics by 120.9% in the 1st quarter. IFP Advisors Inc now owns 47,500 shares of the company's stock worth $31,000 after purchasing an additional 26,000 shares during the last quarter. Raymond James Financial Inc. acquired a new stake in Senseonics in the 4th quarter worth approximately $26,000. Smith Salley Wealth Management acquired a new stake in Senseonics in the 1st quarter worth approximately $36,000. State of Wyoming acquired a new stake in Senseonics in the 1st quarter worth approximately $40,000. Finally, Two Sigma Investments LP acquired a new stake in Senseonics in the 4th quarter worth approximately $36,000. 12.36% of the stock is currently owned by institutional investors and hedge funds.

Senseonics Stock Performance

Shares of NYSE SENS traded down $0.00 during trading hours on Thursday, reaching $0.45. The stock had a trading volume of 16,625,687 shares, compared to its average volume of 8,094,170. The business's fifty day moving average is $0.49 and its two-hundred day moving average is $0.59. The company has a debt-to-equity ratio of 59.17, a current ratio of 2.47 and a quick ratio of 2.38. The company has a market cap of $364.98 million, a price-to-earnings ratio of -3.45 and a beta of 0.93. Senseonics Holdings, Inc. has a twelve month low of $0.25 and a twelve month high of $1.40.

Analyst Ratings Changes

SENS has been the subject of several research reports. Lake Street Capital raised Senseonics to a "strong-buy" rating in a research report on Thursday, July 17th. Wall Street Zen upgraded shares of Senseonics to a "sell" rating in a research note on Monday, May 12th. Barclays started coverage on shares of Senseonics in a research note on Wednesday, August 27th. They set an "overweight" rating and a $1.50 target price for the company. TD Cowen started coverage on shares of Senseonics in a research note on Tuesday, July 15th. They set a "buy" rating and a $1.25 target price for the company. Finally, HC Wainwright reiterated a "buy" rating and set a $1.40 target price (up from $1.10) on shares of Senseonics in a research note on Tuesday, July 8th. Two analysts have rated the stock with a Strong Buy rating and three have given a Buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of "Buy" and an average price target of $1.54.

Senseonics Profile

Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management.